NDC 71610-510 – Terazosin

Terazosin Hydrochloride 2 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC71610-510

Product details

Brand name
Terazosin
Generic name
Terazosin Hydrochloride
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA075317
Marketed since
March 30, 2020
Listing expires
December 31, 2026
Pharmacologic class
alpha-Adrenergic Blocker

Active ingredients

Uses, dosage, side effects and warnings for Terazosin →

Package NDC codes (7)

Package NDCDescriptionSince
71610-510-3030 CAPSULE in 1 BOTTLE (71610-510-30)Dec 29, 2020
71610-510-5360 CAPSULE in 1 BOTTLE (71610-510-53)Dec 29, 2020
71610-510-6090 CAPSULE in 1 BOTTLE (71610-510-60)Dec 29, 2020
71610-510-70120 CAPSULE in 1 BOTTLE (71610-510-70)Dec 29, 2020
71610-510-80180 CAPSULE in 1 BOTTLE (71610-510-80)Dec 29, 2020
71610-510-92270 CAPSULE in 1 BOTTLE (71610-510-92)Dec 29, 2020
71610-510-94360 CAPSULE in 1 BOTTLE (71610-510-94)Dec 29, 2020

Other Terazosin products